Other Neuropsychiatric Disorders & General Information

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

GRATIS 3! - The Impact, Identification, and Management of Attention-Deficit/Hyperactivity Disorder in Adults

Lenard A. Adler, Jeffrey H. Newcorn, and Stephen V. Faraone

CNS Spectr. 2007;12(12 Suppl 23):1-20

 

GRATIS 3 - Malingering of Psychiatric Disorders: A Review

Jaspreet Singh, Ajit Avasthi, and Sandeep Grover

German J Psychiatry 2007; 10: 126-132

 

GRATIS 3 - HIV and Psychiatric Illness

Edward Hammond, and Glenn J. Treisman

Psych Times. December 01, 2007 Vol. 24 No. 14

 

GRATIS 3 - Lyme Disease, Comorbid Tick-Borne Diseases, and Neuropsychiatric Disorders

Robert C. Bransfield

Psych Times December 01, 2007 Vol. 24 No. 14

 

5 - Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

Peter Tyrer, Patricia C Oliver-Africano, Zed Ahmed, Nick Bouras, Sherva Cooray, Shoumitro Deb, Declan Murphy, Monica Hare, Michael Meade, Ben Reece, Kofi Kramo, Sabyasachi Bhaumik, David Harley, Adrienne Regan, David Thomas, Bharti Rao, Bernard North, Joseph Eliahoo, Shamshad Karatela, Anju Soni and Mike Crawford
The Lancet. Volume 371, Issue 9606, 5 January 2008-11 January 2008, Pages 57-63

 

GRATIS 3 - Psychiatric Genetic Counseling: Don't Expect Easy Answers

Joan Arehart-Treichel

Psychiatr News January 4, 2008; Volume 43, Number 1, page 20

5 - Efficacy of Sibutramine for the Treatment of Binge Eating Disorder: A Randomized Multicenter Placebo-Controlled Double-Blind Study

Denise E. Wilfley, Scott J. Crow, James I. Hudson, James E. Mitchell, Robert I. Berkowitz, Vicky Blakesley, B. Timothy Walsh, The Sibutramine Binge Eating Disorder Research Group

Am J Psychiatry 2008; 165:51-58

3 - Co-Occurrence of Binge Eating Disorder With Psychiatric and Medical Disorders

Kristin N. Javaras, Harrison G. Pope, Jr., Justine K. Lalonde, Jacqueline L. Roberts, Yael I. Nillni, Nan M. Laird, Cynthia M. Bulik, Scott J. Crow, Susan L. McElroy, B. Timothy Walsh, Ming T. Tsuang, Norman R. Rosenthal, and James I. Hudson

J Clin Psychiatry January 9, 2008: e1-e8; pii: ej07m03211

 

5 - Efficacy of Memantine on Behavioral and Psychological Symptoms Related to Dementia: A Systematic Meta-Analysis

Ian D Maidment, Chris G Fox, Malaz Boustani, Jorge Rodriguez, Ruth C Brown, Cornelius L Katona

The Annals of Pharmacotherapy: Vol. 42, No. 1, pp. 32-38

5! - Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

Peter Tyrer, Patricia C Oliver-Africano, Zed Ahmed, Nick Bouras, Sherva Cooray, Shoumitro Deb, Declan Murphy, Monica Hare, Michael Meade, Ben Reece, Kofi Kramo, Sabyasachi Bhaumik, David Harley, Adrienne Regan, David Thomas, Bharti Rao, Bernard North, Joseph Eliahoo, Shamshad Karatela, Anju Soni and Mike Crawford

The Lancet 2008; 371:57-63

 

3 - Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments

Fabrizio Benedetti

Annual Review of Pharmacology and Toxicology. Vol. 48: 33-60

 

GRATIS 3 - Current and future management of Alzheimer’s disease

Serge Gauthier and Judes Poirier

Alzheimer's and Dementia. Volume 4, Issue 1, Supplement 1, January 2008, Pages S48-S50

GRATIS 3 - The oldest old and the 90+ Study

Claudia H. Kawas

Alzheimer's and Dementia. Volume 4, Issue 1, Supplement 1, January 2008, Pages S56-S59

GRATIS 3 - Dementia: Is it time for a change in focus�

Lewis H. Kuller and Oscar L. Lopez

Alzheimer's and Dementia. Volume 4, Issue 1, Supplement 1, January 2008, Pages S77-S84

GRATIS 3 - Disease-modifying approaches to Alzheimer’s disease: Challenges and opportunities—Lessons from donepezil therapy

Marwan N. Sabbagh, Sharon Richardson and Norman Relkin

Alzheimer's and Dementia. Volume 4, Issue 1, Supplement 1, January 2008, Pages S109-S118

GRATIS 3! - Prevention therapeutics of dementia

Lon S. Schneider

Alzheimer's and Dementia. Volume 4, Issue 1, Supplement 1, January 2008, Pages S122-S130

GRATIS 3 - More than a decade of estrogen neuroprotection

James W. Simpkins and Meharvan Singh

Alzheimer's and Dementia. Volume 4, Issue 1, Supplement 1, January 2008, Pages S131-S136

GRATIS 3 - Prognosis of Alzheimer’s disease today: A two-year prospective study in 686 patients from the REAL-FR Study

Frédéric Cortes, Fati Nourhashémi, Olivier Guérin, Christelle Cantet, Sophie Gillette-Guyonnet, Sandrine Andrieu, Pierre-Jean Ousset, Bruno Vellas and REAL-FR Group

Alzheimer's and Dementia. Volume 4, Issue 1, January 2008, Pages 22-29

 

GRATIS 3 - One-week dose titration of extended release galantamine in patients with Alzheimer’s disease

Douglas W. Scharre, Thomas Shiovitz, Young Zhu and Joan Amatniek

Alzheimer's and Dementia. Volume 4, Issue 1, January 2008, Pages 30-37

 

GRATIS 3 - Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

Harald Hampel, Katharina Bürger, Stefan J. Teipel, Arun L.W. Bokde, Henrik Zetterberg and Kaj Blennow

Alzheimer's and Dementia. Volume 4, Issue 1, January 2008, Pages 38-48

 

GRATIS 3 - Behavioral effects of current Alzheimer’s disease treatments: A descriptive review

Jeffrey L. Cummings, Joan Mackell and Daniel Kaufer

Alzheimer's and Dementia. Volume 4, Issue 1, January 2008, Pages 49-60

 

4 - Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment

A.S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack, Jr, P. S. Aisen, L. J. Thal, For the Alzheimer's Disease Cooperative Study

NEUROLOGY 2008;70:191-199

3 - A feasibility and tolerability study of lithium in Alzheimer's disease

Alastair Macdonald, Kate Briggs, Michaela Poppe, Andrea Higgins, Latha Velayudhan, Simon Lovestone

International Journal of Geriatric Psychiatry. Early View: 8 Jan 2008

 

4 - Gender Differences in 2 Clinical Trials of Adults With Attention-Deficit/Hyperactivity Disorder: A Retrospective Data Analysis

Reid J. Robison, Frederick W. Reimherr, Barrie K. Marchant, Stephen V. Faraone, Lenard A. Adler, and Scott A. West

J Clin Psychiatry January 16, 2008: e1-e9; pii: ej06m02974

 

3 - Pathological Gambling: An Update on Neuropathophysiology and Pharmacotherapy.

Iancu, Iulian; Lowengrub, Katherine; Dembinsky, Yael; Kotler, Moshe; Dannon, Pinhas N

CNS Drugs. 22(2):123-138, 2008

3 - Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation

D Servello, M Porta, M Sassi, A Brambilla, M M Robertson

Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:136-142

3 - Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

G Lefèvre, G Sedek, S S Jhee, M T Leibowitz, H-La Huang, A Enz, S Maton, L Ereshefsky, F Pommier, H Schmidli and S Appel-Dingemanse

Clinical Pharmacology & Therapeutics (2008) 83, 106–114

 

GRATIS 3 - More Prescribing Decisions to Be Guided by Genetic Tests

Jun Yan

Psychiatr News January 18, 2008; Volume 43, Number 2, page 7

GRATIS 3 - Genomics and Personalized Medicine

Michelle Meadows

FDA Consumer magazine. November-December 2005 Issue

 

5 - Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study

Safarinejad, Mohammad Reza

Journal of Clinical Psychopharmacology. 28(1):39-44, February 2008

3 - Looking to the Future for Erectile Dysfunction Therapies

Hatzimouratidis, Konstantinos; Hatzichristou, Dimitrios G

Drugs, Volume 68, Number 2, 2008 , pp. 231-250

 

3 - Symptoms Related to the Menstrual Cycle: Diagnosis, Prevalence, and Treatment

CLAYTON, ANITA H

Journal of Psychiatric Practice. 14(1):13-21, January 2008

5 - Levetiracetam in Patients With Impulsive Aggression: A Double-Blind, Placebo-Controlled Trial

Jeffrey A. Mattes

J Clin Psychiatry January 23, 2008: e1-e6; pii: ej07m03110

 

3! - Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview

M. Zimmerman, J. B. McGlinchey, I. Chelminski and D. Young

Psychological Medicine (2008), 38:199-210

 

GRATIS 3< - Yi-gan san for the treatment of borderline personality disorder: An open-label study

Tsuyshi Miyaoka, Motohide Furuya, Hideaki Yasuda, Maiko Hayashia, Takuji Inagaki and Jun Horiguchi

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 1, 1 January 2008, Pages 150-154

 

GRATIS 3! - Serum lipid levels and suicidality among male patients with schizoaffective disorder

Darko Marčinko, Vesna Marčinko, Dalibor Karlović, Anita Marčinko, Marko Martinac, Dražen Begić and Miro Jakovljević

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 1, 1 January 2008, Pages 193-196

 

3 - Violent Behavior and DSM-IV Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Attila J. Pulay, Deborah A. Dawson, Deborah S. Hasin, Risë B. Goldstein, W. June Ruan, Roger P. Pickering, Boji Huang, S. Patricia Chou, and Bridget F. Grant

J Clin Psychiatry 2008;69:12-22

 

3 - Classification Trees Distinguish Suicide Attempters in Major Psychiatric Disorders: A Model of Clinical Decision Making

J. John Mann, Steven P. Ellis, Christine M. Waternaux, Xinhua Liu, Maria A. Oquendo, Kevin M. Malone, Beth S. Brodsky, Gretchen L. Haas, and Dianne Currier

J Clin Psychiatry 2008;69:23-31

 

3 - The role of stress in symptom exacerbation among IBS patients

Edward B. Blanchard, Jeffrey M. Lackner, James Jaccard, Dianna Rowell, Ann Marie Carosella, Catherine Powell, Kathryn Sanders, Susan Krasner and Eric Kuhn

Journal of Psychosomatic Research. Volume 64, Issue 2, February 2008, Pages 119-128

 

GRATIS 3! - An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder

John Fayyad

Evidence-Based Mental Health 2008;11:31

3 - Pharmacotherapy of insomnia

Abid Bhat‌, Fariha Shafi‌ & Ali A El Solh

Expert Opinion on Pharmacotherapy. February 2008, Vol. 9, No. 3, Pages 351-362

 

3 - The pharmacologic management of premenstrual dysphoric disorder

Andrea J Rapkin‌ & Sharon A Winer

Expert Opinion on Pharmacotherapy. February 2008, Vol. 9, No. 3, Pages 429-445

 

GRATIS 3! - In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter

Guyatt GH, Mills EJ, Elbourne D

PLoS Med 5(1): e4

 

GRATIS 3! - CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration

Hopewell S, Clarke M, Moher D, Wager E, Middleton P, et al

PLoS Med 5(1): e20

 

GRATIS (requiere registro) 3 - ¿Factores inmunes o depresión? La fatiga relacionada con la enfermedad de Parkinson

Z. Katsarou, S. Bostantjopoulou, O. Hatzizisi, E. Giza, A. Soler-Cardona, G. Kyriazis

REV NEUROL 2007;45:725-728

 

3 - Zolpidem modified-release in insomnia

Cynthia Kirkwood, Jason Neill, Ericka Breden

Neuropsychiatric Disease and Treatment. 2007, Volume 3 Issue 5

 

3! - Potential cognitive enhancing and disease modifi cation effects of SSRIs for Alzheimer’s disease

Tiffany W Chow, Bruce G Pollock, Norton W Milgram

Neuropsychiatric Disease and Treatment. 2007, Volume 3 Issue 5

 

3 - Sleep disturbances and suicide risk: A review of the literature

Rebecca A Bernert, Thomas E Joiner

Neuropsychiatric Disease and Treatment. 2007, Volume 3 Issue 6

 

5< - Olanzapine in the Treatment of Pathological Gambling: A Negative Randomized Placebo-Controlled Trial

Susan L. McElroy, Erik B. Nelson, Jeffrey A. Welge, Laura Kaehler, and Paul E. Keck, Jr

J Clin Psychiatry January 30, 2008: e1-e8

 

5< - Ziprasidone in the Treatment of Borderline Personality Disorder: A Double-Blind, Placebo-Controlled, Randomized Study

Juan Carlos Pascual, Joaquim Soler, Dolors Puigdemont, Rosario Pérez-Egea, Thais Tiana, Enrique Alvarez, and Víctor Pérez

J Clin Psychiatry January 30, 2008: e1-e6

 

3 - Recent developments in the therapy of irritable bowel syndrome

Richard J Saad & William D Chey

Expert Opinion on Investigational Drugs. February 2008, Vol. 17, No. 2, Pages 117-130

 

GRATIS 5< - No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial

de Jong D, Jansen R, Hoefnagels W, Jellesma-Eggenkamp M, Verbeek M, et al

PLoS ONE 3(1): e1475

 

GRATIS 3 - Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up

Jing Xie, Carol Brayne, Fiona E Matthews

BMJ  2008;336:258-262

 

GRATIS 3 - Monitoring and Management of Metabolic Risk Factors in Outpatients Taking Antipsychotic Drugs: A Controlled Study

Amber Jennex, David M Gardner

Can J Psychiatry 2008;53(1):34–42

 

GRATIS 3 - Understanding the Fibromyalgia Syndrome

Srinivas G. Rao, Judith F. Gendreau, and Jay D. Kranzler

Psychopharmacology Bulletin. 2007; 40( 4): 24- 67

.

Regresar a RESÚMENES ENERO 2008